Literature DB >> 30814915

In vivo dosimetry of the rectum in image-guided adaptive interstitial-intracavitary brachytherapy of cervix cancer - A feasibility study.

Georgina Fröhlich1,2, Kinga Dóra Kovács2, Tibor Major1, Csaba Polgár1,3.   

Abstract

AIM AND
BACKGROUND: To investigate the feasibility of in vivo rectal dosimetry in image-guided adaptive brachytherapy of cervical cancer.
MATERIALS AND METHODS: Error of measurement of dose rate in a semiconductor diode probe was investigated depending on the distance and angle in water, and on temperature in a polymethyl methacrylate phantom using an Ir-192 source. Furthermore, the difference between the measured and calculated dose was analysed in the interstitial brachytherapy of 30 cervix cancer patients. The relationship between in vivo measured dose, calculated dose in the point of the diode, calculated maximal dose in the point of the diodes and calculated maximal dose of the rectum were examined.
RESULTS: The dosimeter measured with 85% accuracy at more than 5 cm from the source, but within a closer distance the accuracy decreased significantly. At 45-90° angle, the device measured with a 15% error. The error increased with the temperature, 22% at 35 °C. In 8 cases (26.7%) the maximal dose was measured in the correct diode. The device measured 73% of the calculated dose in the point of the diode. The maximum of the calculated doses of diodes was 60% of the calculated maximal dose. The in vivo measured dose was 35% of the calculated maximal dose.
CONCLUSIONS: Under treatment conditions, the semiconductor diode does not provide reliable measured data. The probe pushes the rectal wall closer to the high dose areas and underestimates the dose of it. Semiconductor probe is not recommended for in vivo dosimetry of the rectum in image-guided brachytherapy of cervical cancer.

Entities:  

Keywords:  Cervical cancer; Dosimetry; In vivo; Interstitial brachytherapy; Rectal dose

Year:  2019        PMID: 30814915      PMCID: PMC6378658          DOI: 10.1016/j.rpor.2019.01.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  16 in total

1.  In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix.

Authors:  R Alecu; M Alecu
Journal:  Med Phys       Date:  1999-05       Impact factor: 4.071

2.  In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.

Authors:  Claudia Waldhäusl; André Wambersie; Richard Pötter; Dietmar Georg
Journal:  Radiother Oncol       Date:  2005-10-14       Impact factor: 6.280

3.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

Authors:  Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits
Journal:  Radiother Oncol       Date:  2006-01-05       Impact factor: 6.280

4.  A plastic scintillation dosimeter for high dose rate brachytherapy.

Authors:  J Lambert; D R McKenzie; S Law; J Elsey; N Suchowerska
Journal:  Phys Med Biol       Date:  2006-10-09       Impact factor: 3.609

5.  In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector.

Authors:  Jamil Lambert; Tatsuya Nakano; Sue Law; Justin Elsey; David R McKenzie; Natalka Suchowerska
Journal:  Med Phys       Date:  2007-05       Impact factor: 4.071

Review 6.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

Authors:  Christine Haie-Meder; Richard Pötter; Erik Van Limbergen; Edith Briot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Taran Paulsen Hellebust; Christian Kirisits; Stefan Lang; Sabine Muschitz; Juliana Nevinson; An Nulens; Peter Petrow; Natascha Wachter-Gerstner
Journal:  Radiother Oncol       Date:  2005-03       Impact factor: 6.280

7.  Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.

Authors:  Johannes C A Dimopoulos; Stefan Lang; Christian Kirisits; Elena F Fidarova; Daniel Berger; Petra Georg; Wolfgang Dörr; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

8.  Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy.

Authors:  Johannes C A Dimopoulos; Richard Pötter; Stefan Lang; Elena Fidarova; Petra Georg; Wolfgang Dörr; Christian Kirisits
Journal:  Radiother Oncol       Date:  2009-08-11       Impact factor: 6.280

9.  Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.

Authors:  Richard Pötter; Johannes Dimopoulos; Petra Georg; Stefan Lang; Claudia Waldhäusl; Natascha Wachter-Gerstner; Hajo Weitmann; Alexander Reinthaller; Tomas Hendrik Knocke; Stefan Wachter; Christian Kirisits
Journal:  Radiother Oncol       Date:  2007-05       Impact factor: 6.280

10.  Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy.

Authors:  Petra Georg; Christian Kirisits; Gregor Goldner; Wolfgang Dörr; Johann Hammer; Regina Pötzi; Daniel Berger; Johannes Dimopoulos; Dietmar Georg; Richard Pötter
Journal:  Radiother Oncol       Date:  2009-02-23       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.